Cargando…

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity

BACKGROUND: A variety of hypofractionated radiotherapy schedules has been proposed after breast conserving surgery in the attempt to shorten the overall treatment time. The aim of the present study is to assess acute and late toxicity of using daily fractionation of 2.25 Gy to a total dose of 45 Gy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deantonio, Letizia, Gambaro, Giuseppina, Beldì, Debora, Masini, Laura, Tunesi, Sara, Magnani, Corrado, Krengli, Marco
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000406/ https://www.ncbi.nlm.nih.gov/pubmed/21092288 http://dx.doi.org/10.1186/1748-717X-5-112

Ejemplares similares

FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma
por: Deantonio, Letizia, et al.
Publicado: (2008)

Prone versus supine position for adjuvant breast radiotherapy: a prospective study in patients with pendulous breasts
por: Krengli, Marco, et al.
Publicado: (2013)

Impact of ATM rs1801516 on late skin reactions of radiotherapy for breast cancer: Evidences from a cohort study and a trial sequential meta-analysis
por: Terrazzino, Salvatore, et al.
Publicado: (2019)

DNA Methyltransferase Gene Polymorphisms for Prediction of Radiation-Induced Skin Fibrosis after Treatment of Breast Cancer: A Multifactorial Genetic Approach
por: Terrazzino, Salvatore, et al.
Publicado: (2017)

Similar Outcomes of Standard Radiotherapy and Hypofractionated Radiotherapy Following Breast-Conserving Surgery
por: Hou, Hai-Ling, et al.
Publicado: (2015)

Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity
por: Guenzi, Marina, et al.
Publicado: (2015)

Hypofractionated radiotherapy after conservative surgery may increase low–intermediate grade late fibrosis in breast cancer patients
por: Digesù, Cinzia, et al.
Publicado: (2018)

Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancers
por: Krengli, Marco, et al.
Publicado: (2017)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Reproducibility of patient setup by surface image registration system in conformal radiotherapy of prostate cancer
por: Krengli, Marco, et al.
Publicado: (2009)

Robustness of hypofractionated breast radiotherapy after breast-conserving surgery with free breathing
por: Chen, Kunzhi, et al.
Publicado: (2023)

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity
por: Chitapanarux, Imjai, et al.
Publicado: (2019)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

Three-dimensional surface and ultrasound imaging for daily IGRT of prostate cancer
por: Krengli, Marco, et al.
Publicado: (2016)

Correlation of [(18)F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
por: Pisani, C., et al.
Publicado: (2021)

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma
por: Krengli, Marco, et al.
Publicado: (2010)

Radiotherapy in COVID-19 patient affected by multiple myeloma: a case report
por: Krengli, Marco, et al.
Publicado: (2020)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality
por: Akgun, Zuleyha, et al.
Publicado: (2023)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
por: Schmitt, Martin, et al.
Publicado: (2022)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
por: Barra, Salvina, et al.
Publicado: (2018)

Targeted Next-Generation Sequencing for the Identification of Genetic Predictors of Radiation-Induced Late Skin Toxicity in Breast Cancer Patients: A Preliminary Study
por: Cargnin, Sarah, et al.
Publicado: (2021)

Image Guided Hypofractionated Radiotherapy by Helical Tomotherapy for Prostate Carcinoma: Toxicity and Impact on Nadir PSA
por: Barra, Salvina, et al.
Publicado: (2014)

Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years
por: Pinnarò, Paola, et al.
Publicado: (2010)

High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
por: HUANG, BING-SHEN, et al.
Publicado: (2013)

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors
por: Ciammella, Patrizia, et al.
Publicado: (2014)

Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity
por: Youssef, Ashraf, et al.
Publicado: (2018)

Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis
por: Dong, Jinling, et al.
Publicado: (2021)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Evaluation of DIBH and VMAT in Hypofractionated Radiotherapy for Left-Sided Breast Cancers After Breast-Conserving Surgery: A Planning Study
por: Tang, Liuwei, et al.
Publicado: (2021)

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: Toxicity and quality of life assessment
por: Rucinska, Monika, et al.
Publicado: (2016)

Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
por: Kim, Dong-Yun, et al.
Publicado: (2020)

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
por: Tamihardja, Jörg, et al.
Publicado: (2020)

Hypofractionated radiotherapy in postmastectomy locally advanced breast cancer: an interim report on acute toxicities and dosimetry
por: Jamora, Kurl, et al.
Publicado: (2022)

Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound
por: Landoni, Valeria, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m21s65ve0f9mcr1qb6f3gjkgjc